Patent: 5,302,400
✉ Email this page to a colleague
Summary for Patent: 5,302,400
Title: | Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids |
Abstract: | Disclosed are gastric acid-resistant polymer-coated digestive enzymes/buffered-bile acid compositions, process for their preparations and methods of treating digestive disorders, impaired liver function, cystic fibrosis, regulating the absorption of dietary cholesterol, and for dissolving gallstones by administering said compositions to a mammal in need of such treatment. |
Inventor(s): | Sipos; Tibor (Lebanon, NJ) |
Assignee: | Digestive Care Inc. (Lebanon, NJ) |
Application Number: | 07/901,758 |
Patent Claims: | see list of patent claims |
Details for Patent 5,302,400
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Discure Medical, Llc | CHYMODIACTIN | chymopapain | For Injection | 018663 | 11/10/1982 | ⤷ Try a Trial | 2040-03-30 |
Discure Medical, Llc | CHYMODIACTIN | chymopapain | For Injection | 018663 | 08/21/1984 | ⤷ Try a Trial | 2040-03-30 |
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | COTAZYM | pancrelipase | Capsule, Delayed Release | 020580 | 12/09/1996 | ⤷ Try a Trial | 2040-03-30 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 04/30/2009 | ⤷ Try a Trial | 2040-03-30 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 06/10/2011 | ⤷ Try a Trial | 2040-03-30 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,302,400
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 4132993 | ⤷ Try a Trial |
Canada | 2096004 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |